Clinical Trial Update: Effects of 2 Different Duration of Albendazole Therapy in Patients With Neurocysticercosis in Brain ≤ 5 Lesions on CT [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing two durations of albendazole therapy in patients with neurocysticercosis (brain involvement with up to 5 lesions on CT) has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurocysticercosis

Drugs mentioned

• Albendazole (ALBENDAZOLE)

Snippet

Sponsor: All India Institute of Medical Sciences | Conditions: Neurocysticercosis | Phase 3 | Status: COMPLETED